Zoeken
Zoeken kan via de modus 'eenvoudig zoeken' (één veld) of uitgebreid via 'geavanceerd zoeken' (meerdere velden). Zo kan je bv. zoeken op een combinatie van een auteursnaam (auteur), een jaartal (jaar) en een documenttype.
Boekenmand
Nuttige resultaten kan je aanvinken en toevoegen aan een mandje. De inhoud hiervan kan je exporteren of afdrukken (naar bv. PDF).
RSS
Op de hoogte blijven van nieuw toegevoegde publicaties binnen uw interessegebied? Dit kan door een RSS-feed (?) te maken van jouw zoekopdracht.
nieuwe zoekopdracht
A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and immunological health conditions in humans
Chang, E.T.; Adami, H.-O.; Boffetta, P.; Wedner, H.J.; Mandel, J.S. (2016). A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and immunological health conditions in humans. Critical Reviews in Toxicology 46(4): 279-331. https://dx.doi.org/10.3109/10408444.2015.1122573
In: Critical Reviews in Toxicology. Taylor & Francis: Abingdon. ISSN 1040-8444; e-ISSN 1547-6898
|   |
| Trefwoorden |
|
| Author keywords |
Asthma; autoimmune diseases; CAS No. 335-67-1; CAS No. 1763-23-1; hypersensitivity; immune system; immunological factors; infection; perfluoroalkyl substances; polyfluoroalkyl substances |
| Auteurs | | Top |
- Chang, E.T.
- Adami, H.-O.
- Boffetta, P.
|
- Wedner, H.J.
- Mandel, J.S.
|
|
| Abstract |
Whether perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS), two widely used and biopersistent synthetic chemicals, are immunotoxic in humans is unclear. Accordingly, this article systematically and critically reviews the epidemiologic evidence on the association between exposure to PFOA and PFOS and various immune-related health conditions in humans. Twenty-four epidemiologic studies have reported associations of PFOA and/or PFOS with immune-related health conditions, including ten studies of immune biomarker levels or gene expression patterns, ten studies of atopic or allergic disorders, five studies of infectious diseases, four studies of vaccine responses, and five studies of chronic inflammatory or autoimmune conditions (with several studies evaluating multiple endpoints). Asthma, the most commonly studied condition, was evaluated in seven studies. With few, often methodologically limited studies of any particular health condition, generally inconsistent results, and an inability to exclude confounding, bias, or chance as an explanation for observed associations, the available epidemiologic evidence is insufficient to reach a conclusion about a causal relationship between exposure to PFOA and PFOS and any immune-related health condition in humans. When interpreting such studies, an immunodeficiency should not be presumed to exist when there is no evidence of a clinical abnormality. Large, prospective studies with repeated exposure assessment in independent populations are needed to confirm some suggestive associations with certain endpoints. |
IMIS is ontwikkeld en wordt gehost door het VLIZ.
